Serological assays for emerging coronaviruses: Challenges and pitfalls
Top Cited Papers
- 23 March 2014
- journal article
- review article
- Published by Elsevier BV in Virus Research
- Vol. 194, 175-183
- https://doi.org/10.1016/j.virusres.2014.03.018
Abstract
No abstract availableKeywords
Funding Information
- EMPERIE
- ANTIGONE
This publication has 92 references indexed in Scilit:
- The Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing AntibodiesJournal of Virology, 2013
- Human Betacoronavirus 2c EMC/2012–related Viruses in Bats, Ghana and EuropeEmerging Infectious Diseases, 2013
- Serology-Enabled Discovery of Genetically Diverse Hepaciviruses in a New HostJournal of Virology, 2012
- The dominance of human coronavirus OC43 and NL63 infections in infantsJournal of Clinical Virology, 2012
- Bats host major mammalian paramyxovirusesNature Communications, 2012
- Prevalence of Antibodies to Four Human Coronaviruses Is Lower in Nasal Secretions than in SerumClinical and Vaccine Immunology, 2010
- Examination of seroprevalence of coronavirus HKU1 infection with S protein-based ELISA and neutralization assay against viral spike pseudotyped virusJournal of Clinical Virology, 2009
- Proteomics Analysis Unravels the Functional Repertoire of Coronavirus Nonstructural Protein 3Journal of Virology, 2008
- SARS coronavirus accessory proteinsVirus Research, 2008
- The ORF7b Protein of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Is Expressed in Virus-Infected Cells and Incorporated into SARS-CoV ParticlesJournal of Virology, 2007